AUS
NZ
UK
CA
USA
IND
Healthcare
Does Cochlear's (ASX:COH) Bounce Have Room After A Deep Fall?
July 17, 2026 11:16 PM AEST| By Vivek SinghCochlear shares have bounced as broader ASX healthcare sentiment steadied, reviving debate over whether the recovery in the premium-rated hearing-implant maker has further room after a deep slide.
Why Is Pro Medicus (ASX:PME) Turning Heads Right Now?
July 17, 2026 11:16 PM AEST| By SamSpecialist ASX healthcare names in medical imaging software and radiopharmaceuticals have held the spotlight as clinical and commercial milestones fuel interest, with the market weighing rich valuations against long growth runways.
ASX Healthcare Shares Extend Their Rebound Off A Low Base
July 17, 2026 11:16 PM AEST| By SamThe ASX healthcare sector has rebounded sharply off a multi-year low, led by plasma and sleep-device names, with the market awaiting results season to test whether earnings support the recovery.
Neuren (ASX:NEU): What Keeps Healthcare Markets Watching?
July 17, 2026 01:36 PM AEST| By SamNeuren remains in focus as regulatory progress, royalty visibility, clinical evidence, market uptake, partner execution and disciplined pipeline development shape a selective Australian biotechnology and healthcare sentiment debate today.
Top Healthcare Stocks: Why Is Recce Pharmaceuticals (ASX:RCE) in Focus?
July 17, 2026 01:36 PM AEST| By SamRecce Pharmaceuticals remains in focus as anti-infective research, clinical development, intellectual property and disciplined execution continue shaping sentiment across Australia's biotechnology sector.
Why Is ResMed (ASX:RMD) Driving The Healthcare Reset?
July 17, 2026 11:08 AM AEST| By SamResMed remains central to the healthcare reset as portfolio clarity, sleep-device demand, margin discipline and capital allocation shape its position in a selective Australian market cycle.
Can Cochlear (ASX:COH) Balance Product Innovation With Valuation Questions?
July 17, 2026 10:11 AM AEST| By SamCochlear continues expanding its hearing technology portfolio through its latest Osia sound processor, reinforcing its focus on innovation, customer upgrades and long-term healthcare solutions.
CSL (ASX:CSL) Sparks Healthcare Comeback, But Can the Rally Last?
July 16, 2026 10:10 PM AEST| By Vivek SinghAustralian healthcare shares have rebounded strongly from multi-year lows, led by CSL, Cochlear and ResMed, with upcoming earnings expected to determine whether the recovery can maintain its momentum.
Telix Pharmaceuticals (ASX:TLX): Biotech Momentum Builds on Key Milestone
July 16, 2026 10:07 PM AEST| By SamTelix Pharmaceuticals approaches an important overseas regulatory decision while Neuren and Mesoblast continue advancing commercial and clinical programs, keeping Australia's biotechnology sector firmly in focus through expanding healthcare innovatio...
Pro Medicus (ASX:PME) in Focus: What Could Healthcare Results Reveal?
July 16, 2026 10:05 PM AEST| By SamPro Medicus, Sonic Healthcare and Ramsay Health Care return to focus before reporting season, offering valuable insights into healthcare technology, diagnostics, hospital activity and the evolving demand for medical services.
Why Does COH Remain Central to Healthcare Stock Debate?
July 16, 2026 01:07 PM AEST| By SamCOH remains on healthcare watchlists as implant demand, clinic activity, product innovation, currency pressure and disciplined execution shape the global hearing device company’s Australian market narrative.
Why Is ResMed RMD Driving Healthcare Stocks Attention Now?
July 16, 2026 01:07 PM AEST| By SamRMD remains a key Healthcare Stocks discussion as Australian markets balance global health demand, disciplined execution, digital healthcare growth, operational consistency and selective sector leadership amid evolving macroeconomic conditions.
Why Is CSL a Top Healthcare Stock to Watch Now?
July 16, 2026 01:06 PM AEST| By SamCSL remains in healthcare focus as plasma demand, collection efficiency, margin repair, research productivity and global scale shape the credibility of its evolving biotechnology operating model.
Could Chimeric’s Latest Cancer Trial Signal a Turning Point?
July 16, 2026 10:54 AM AEST| By SamChimeric Therapeutics reported encouraging interim CAR-T trial results showing tumour shrinkage and sustained disease stability, while upcoming clinical milestones and programme funding remain important areas of focus.
How Have Margin Pressures and Leadership Changes Shaped CSL's Outlook?
July 16, 2026 10:18 AM AEST| By SamCSL remains in focus as markets assess margin pressures, leadership changes, cash flow generation and capital management, while the company's global plasma therapies and healthcare operations continue supporting its long-term business strategy.
Why Did EMVision Medical Devices (ASX:EMV) Surge After Its Latest Clinical Update?
July 16, 2026 09:37 AM AEST| By SamEMVision Medical Devices strengthened market attention after reporting progress across pivotal clinical trials, emergency healthcare studies and upcoming FDA engagement as it advances portable brain imaging technology for stroke diagnosis.
Telix Pharmaceuticals (ASX:TLX): What's Fueling the Radiopharma Rally?
July 15, 2026 10:41 PM AEST| By SamAustralia's radiopharmaceutical and medical imaging companies are attracting attention as precision medicine, targeted cancer therapies and advanced diagnostics reshape healthcare through commercial expansion and ongoing scientific innovation.
Sonic (ASX:SHL): Can Defensive Healthcare Services Sustain Their Comeback?
July 15, 2026 10:40 PM AEST| By SamAustralia's pathology, imaging and hospital operators continue strengthening the healthcare recovery through recurring demand, disciplined cost management and operational efficiency, with Sonic Healthcare, Ramsay Health Care and Healius reflecting va...
CSL (ASX:CSL) Leads Healthcare Comeback as Market Mood Shifts
July 15, 2026 10:38 PM AEST| By SamAustralia's healthcare sector has rebounded strongly as defensive rotation returned to favour, with CSL leading the recovery while the upcoming reporting season will determine whether improving earnings can sustain momentum.
Healthcare Leaders Drawing Attention Across Australia's Listed Market
July 15, 2026 04:14 PM AEST| By SamExplore how Australia's leading healthcare companies compare on executive remuneration, what influences executive pay, and why healthcare businesses remain important across the Australian share market.
Advertise your brand on Kalkine Media